Pharma Admet Testing Market Scope And Analysis

Pharma ADMET Testing Market Report Scope

Global Pharma ADMET Testing Market – Segmentation

The pharma ADMET testing market is segmented on the basis of testing type, technology, application, and geography. Based on testing type, the market is segmented into in vivo ADMET testing, in vitro ADMET testing, and in silico ADMET testing. Based on technology, the market is segmented into cell culture, high throughput, molecular imaging, and OMICS technology. Based on application, the global pharma ADMET testing market is segmented into systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Company Profiles

• CMIC Holdings Co., Ltd.
• Charles River Laboratories
• WuXi AppTec
• Promega Corporation
• Merck KGaA
• Agilient Technologies, Inc.
• Biovia (Dassault Systemes)
• Cyprotex Limited
• Bio-Rad Laboratories
• IQVIA Inc.